BioLife Solutions, Inc. Accumulated Other Comprehensive Income
BioLife Solutions, Inc. (BLFS) had Accumulated Other Comprehensive Income of -$211.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$211.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$120.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $132.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $130.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$211.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | -$120.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $132.00K 10-Q · filed 2026-08-06 |
| 2025-09-30 | $130.00K 10-Q · filed 2025-11-06 |
| 2025-06-30 | $71.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $33.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $24.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$208.00K 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$555.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | -$566.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | -$345.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | -$660.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$499.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$534.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$679.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | -$1.26M 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$900.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$438.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | -$282.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | -$163.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $3.00K 10-Q · filed 2021-08-16 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |